N@N

Furiex Pharmaceuticals, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York September 12-15, 20

^{Published on 2010-08-30 13:45:30 - Market Wire}
 

MORRISVILLE, N.C.--([ BUSINESS WIRE ])--Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) announced today that it will present at Rodman & Renshawa™s 12th Annual Healthcare Conference in New York on Monday, September 13, 2010, at 2:50 p.m. ET. Dr. Fred Eshelman, the companya™s chairman, will provide a corporate overview and discuss [ Furiexa™s pipeline ].

A live webcast of the presentation will be available on the [ Rodman & Renshaw website ]. An archived recording of the presentation will also be available on Furiex's website at [ www.furiex.com ].

About Furiex

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through the drug discovery and development process in a cost-efficient manner. Development programs are designed and driven by a core [ team ] with extensive drug development experience. The company collaborates with pharmaceutical and biotechnology companies and has a strong, diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and two products on the market. The companya™s mission is to develop innovative medicines faster and at less cost, reducing the expense of health care globally while providing life-improving therapies for patients. For more information, visit [ www.furiex.com ].